Skip to Main Content
May 08, 2020

Health Law Weekly

Apotex to Pay $24.1 Million to Resolve Price-Fixing Allegations

  • May 08, 2020

Generic drug company Apotex Corp. agreed to pay $24.1 million to settle criminal allegations that it conspired with other sellers to fix prices of the widely used cholesterol medication pravastatin, the Department of Justice (DOJ) announced May 7.

You must be logged in to access this content.